Ricardo Mora-Rodriguez1, V E Fernandez-Elias2, F Morales-Palomo3, J G Pallares4, M Ramirez-Jimenez3, J F Ortega3. 1. Exercise Physiology Laboratory at Toledo, University of Castilla-La Mancha, 45071, Toledo, Spain. ricardo.mora@uclm.es. 2. Physical Activity and Sports Department, Universidad Europea de Madrid, Madrid, Spain. 3. Exercise Physiology Laboratory at Toledo, University of Castilla-La Mancha, 45071, Toledo, Spain. 4. Human Performance and Sport Science Laboratory, University of Murcia, Murcia, Spain.
Abstract
PURPOSE: The aim of this study was to determine the effects of high-intensity aerobic interval training (AIT) on exercise hemodynamics in metabolic syndrome (MetS) volunteers. METHODS:Thirty-eight, MetS participants were randomly assigned to a training (TRAIN) or to a non-training control (CONT) group. TRAIN consisted of stationary interval cycling alternating bouts at 70-90% of maximal heart rate during 45 min day-1 for 6 months. RESULTS: CONT maintained baseline physical activity and no changes in cardiovascular function or MetS factors were detected. In contrast, TRAIN increased cardiorespiratory fitness (14% in VO2PEAK; 95% CI 9-18%) and improved metabolic syndrome (-42% in Z score; 95% CI 83-1%). After TRAIN, the workload that elicited a VO2 of 1500 ml min-1 increased 15% (95% CI 5-25%; P < 0.001). After TRAIN when subjects pedaled at an identical submaximal rate of oxygen consumption, cardiac output increased by 8% (95% CI 4-11%; P < 0.01) and stroke volume by 10% (95% CI, 6-14%; P < 0.005) being above the CONT group values at that time point. TRAIN reduced submaximal exercise heart rate (109 ± 15-106 ± 13 beats min-1; P < 0.05), diastolic blood pressure (83 ± 8-75 ± 8 mmHg; P < 0.001) and systemic vascular resistances (P < 0.01) below CONT values. Double product was reduced only after TRAIN (18.2 ± 3.2-17.4 ± 2.4 bt min-1 mmHg 10-3; P < 0.05). CONCLUSIONS: The data suggest that intense aerobic interval training improves hemodynamics during submaximal exercise in MetS patients. Specifically, it reduces diastolic blood pressure, systemic vascular resistances, and the double product. The reduction in double product, suggests decreased myocardial oxygen demands which could prevent the occurrence of adverse cardiovascular events during exercise in this population. CLINICALTRIALS. GOV IDENTIFIER: NCT03019796.
RCT Entities:
PURPOSE: The aim of this study was to determine the effects of high-intensity aerobic interval training (AIT) on exercise hemodynamics in metabolic syndrome (MetS) volunteers. METHODS: Thirty-eight, MetS participants were randomly assigned to a training (TRAIN) or to a non-training control (CONT) group. TRAIN consisted of stationary interval cycling alternating bouts at 70-90% of maximal heart rate during 45 min day-1 for 6 months. RESULTS: CONT maintained baseline physical activity and no changes in cardiovascular function or MetS factors were detected. In contrast, TRAIN increased cardiorespiratory fitness (14% in VO2PEAK; 95% CI 9-18%) and improved metabolic syndrome (-42% in Z score; 95% CI 83-1%). After TRAIN, the workload that elicited a VO2 of 1500 ml min-1 increased 15% (95% CI 5-25%; P < 0.001). After TRAIN when subjects pedaled at an identical submaximal rate of oxygen consumption, cardiac output increased by 8% (95% CI 4-11%; P < 0.01) and stroke volume by 10% (95% CI, 6-14%; P < 0.005) being above the CONT group values at that time point. TRAIN reduced submaximal exercise heart rate (109 ± 15-106 ± 13 beats min-1; P < 0.05), diastolic blood pressure (83 ± 8-75 ± 8 mmHg; P < 0.001) and systemic vascular resistances (P < 0.01) below CONT values. Double product was reduced only after TRAIN (18.2 ± 3.2-17.4 ± 2.4 bt min-1 mmHg 10-3; P < 0.05). CONCLUSIONS: The data suggest that intense aerobic interval training improves hemodynamics during submaximal exercise in MetS patients. Specifically, it reduces diastolic blood pressure, systemic vascular resistances, and the double product. The reduction in double product, suggests decreased myocardial oxygen demands which could prevent the occurrence of adverse cardiovascular events during exercise in this population. CLINICALTRIALS. GOV IDENTIFIER: NCT03019796.
Authors: J H Wilmore; P R Stanforth; J Gagnon; T Rice; S Mandel; A S Leon; D C Rao; J S Skinner; C Bouchard Journal: Med Sci Sports Exerc Date: 2001-01 Impact factor: 5.411
Authors: Arnt Erik Tjønna; Sang Jun Lee; Øivind Rognmo; Tomas O Stølen; Anja Bye; Per Magnus Haram; Jan Pål Loennechen; Qusai Y Al-Share; Eirik Skogvoll; Stig A Slørdahl; Ole J Kemi; Sonia M Najjar; Ulrik Wisløff Journal: Circulation Date: 2008-07-07 Impact factor: 29.690
Authors: José González-Alonso; José A L Calbet; Robert Boushel; Jørn W Helge; Hans Søndergaard; Thor Munch-Andersen; Gerrit van Hall; Stefan P Mortensen; Niels H Secher Journal: Exp Physiol Date: 2015-09-13 Impact factor: 2.969
Authors: Jesús Martínez-Martínez; Sixto González-Víllora; Javier Valenciano Valcárcel; Juan Carlos Pastor-Vicedo Journal: Int J Environ Res Public Health Date: 2020-06-27 Impact factor: 3.390
Authors: Jose Suryanegara; Sophie Cassidy; Vladan Ninkovic; Dejana Popovic; Miljan Grbovic; Nduka Okwose; Michael I Trenell; Guy G MacGowan; Djordje G Jakovljevic Journal: Acta Diabetol Date: 2018-11-01 Impact factor: 4.280
Authors: I Serrablo-Torrejon; A Lopez-Valenciano; M Ayuso; E Horton; X Mayo; G Medina-Gomez; G Liguori; A Jimenez Journal: BMC Endocr Disord Date: 2020-11-10 Impact factor: 2.763